Jun 21, 20221 min readAsha Therapeutics presents at 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology ConferenceSam Shrivastava (Asha CEO) and Dr. Bradlee Heckmann (Asha CSO) present updates on neuro-oncology assets and ASHA-044
Sam Shrivastava (Asha CEO) and Dr. Bradlee Heckmann (Asha CSO) present updates on neuro-oncology assets and ASHA-044
Comments